ETLI:F:F-Legal & General UCITS ETF Plc - L&G Pharma Breakthrough UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 8.619

Change

+0.09 (+1.00)%

Market Cap

USD 0.02B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-23 )

ETFs Containing ETLI:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -8.03% 12% F 33% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -8.03% 11% F 31% F
Trailing 12 Months  
Capital Gain -18.50% 10% F 32% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -18.50% 10% F 30% F
Trailing 5 Years  
Capital Gain -0.53% 33% F 46% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.53% 32% F 33% F
Average Annual (5 Year Horizon)  
Capital Gain 3.05% 58% F 60% D-
Dividend Return 3.05% 57% F 55% F
Total Return N/A 25% F 34% F
Risk Return Profile  
Volatility (Standard Deviation) 12.81% 50% F 74% C
Risk Adjusted Return 23.80% 53% F 58% F
Market Capitalization 0.02B 8% B- 17% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.